Centrexion Therapeutics Corporationhttps://pcaobus.org/form-ap-filings/30670/30670Centrexion Therapeutics Corporation3067011/12/2018 11:33:37 PM20176f07b9c8-5c4e-4c9e-838b-8a9926aa0f14185KPMG LLP573428Centrexion Therapeutics Corporation1592052CNTX0018500480Christopher John Vanella0018500480True
Centrexion Therapeutics Corporationhttps://pcaobus.org/form-ap-filings/30385/30385Centrexion Therapeutics Corporation3038510/29/2018 8:13:48 PM20172b88ec18-6578-4564-bd29-27648aa0b6a8185KPMG LLP573428Centrexion Therapeutics Corporation1592052CNTX0018500480Christopher John Vanella0018500480True
Alzheon, Inc.https://pcaobus.org/form-ap-filings/22163/22163Alzheon, Inc.221634/9/2018 7:06:20 PM2017c3a02e08-0f1e-4db7-8631-6cb6e3f20118185KPMG LLP564628Alzheon, Inc.1582636ALZH0018500480Christopher John Vanella0018500480True
Alzheon, Inc.https://pcaobus.org/form-ap-filings/20416/20416Alzheon, Inc.204163/26/2018 1:04:27 PM20177f56ed4f-ec13-4251-8a55-631f99b90e44185KPMG LLP564628Alzheon, Inc.1582636ALZH0018500480Christopher John Vanella0018500480True